medigraphic.com
Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular

2013, Number 2

<< Back Next >>

Rev Mex Angiol 2013; 41 (2)

Manejo de la enfermedad tromboembólica venosa

Paz-Janeiro JL, Guzmán-Cruz LA, Pérez-Damián V, Barrios-Cedrún IR, Cortina-Nascimento A, Benites-Palacio S, Rojas-Guevara PA

Language: Spanish
References: 31
Page: 69-77
PDF size: 187.96 Kb.


ABSTRACT

Background: Venous thromboembolism (VTE) is a serious condition and frecuently fatal. Because of this, the importance of timely identification of risk factors in order to carry out an adequate prophylaxis and in the case, to give an adequate treatment.
Objective: To analyze the prophylactic, medical and surgical treatment of venous thromboembolism and identify frequencies, relationships and predictability of the disease with the studied variables.
Material and methods: Cross-sectional and retrospective study, held in the Hospital Español de México over a period of two years. Data were collected from medical records, including the calculation of scales of Wells, Caprini and several variables.
Results: We included 105 patients with evidence of VTE, of which, most of them are found at high risk and likelihood of developing the disease. Prophylaxis was applied to 9% and it was observed that in a large proportion of the patients that are not handled by angiology, the anticoagulant therapy was administered at levels below those recommended by the American College of Chest Physicians (ACCP) and it was associated with a higher rate of complications, especially with the use of low molecular weight heparin.
Conclusions: Despite the availability of effective thromboprophylaxis and wide dissemination of clinical guidelines, this is poorly used or prescribed inappropriately. Adherence to the guidelines of prophylaxis and treatment, decreases complications substantially.


REFERENCES

  1. Zavaleta E, Morales J. Tromboembolia pulmonar. Neumología y Cirugía de Tórax 2006; 65(1).

  2. Martínez M, Castañón J. Enfermedad tromboembólica venosa en la unidad de cuidados intensivos. Rev Med IMSS 2002; 40(3): 233-45.

  3. Martínez-Zubieta R. Tromboembolismo venoso y profilaxis en enfermedades agudas hospitalarias. Resultados en México de un estudio transversal multicéntrico (ENDORSE II). Cirugía y cirujanos 2010; 78: 333-41.

  4. Girard P, Musset, Parent F, et al. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 1999; 116: 903-8.

  5. Torbicki A, Van Bee EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-26.

  6. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 99; 353: 167-73.

  7. Caprini, Joseph A. Thrombosis risk assessment as guide to quality patient care. DM 2005.

  8. Guyat G, Norris S, Schulman S, Hirsh J, Eckman M, Akl E, Crowther M, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic therapy and prevention of thrombosis 9th ed: American college of chest physicians Evidence-Based clinical practice guidelines. Chest 2012; 141; 53S-70S.

  9. Tapson V, Decousus H, Pini M, Chong B, Froehlich J, Monreal M, Spyropoulos A, et al. Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients. Findings From the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-45.

  10. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based clinical practice guidelines 8th edition. Chest 2008; 133 (6 Suppl.): 381S-453S.

  11. Amin A, Lin J, Ryan A. Lack of thromboprophylaxis across the care continuum in US medical patients. Hospital Practice 2010; 38(3): 17-25.

  12. Zaragoza-Delgadillo J, Sauri-Arce C, Ochoa-Carrillo F, Fuentes-del-Toro S. Prevención de la enfermedad tromboembólica venosa en cirugía. Gac Med Mex 2007; 143(Supl. 1): 35-9.

  13. García D, Baglin T, Weitz J, Samama M. Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141; e24S-e43S.

  14. Douketis J, Spyropoulos A, Spencer F, Mayr M, Jaffer A, Eckman M, Dunn A, Kunz R. Perioperative Management of antithrombotic therapy: Antithrombotic therapy and prevention, 9th ed: American College of Chest Physicians Evidence-Based Clinical Guidelines. Chest 2012; 141; e326S-e350S.

  15. Cabrera-Rayo A, Martínez R, Sobrevilla P, Cantú C, Alcántar E, Vázquez MD, Xibillé D. Prevención de la enfermedad tromboembólica venosa en medicina interna. Gac Med Mex 2007; 143(Supl. 1): 29-32.

  16. Guyat G, Akl E, Crowther M, Gutterman D, Schuünemann H. Executive summary: Antithrombotic therapy and prevention of thrombosis 9th ed: American college of chest physicians Evidence-Based clinical practice guidelines. Chest 2012; 141: 7S-47S.

  17. Arnaoutakis G, Pirrucello J, Brooke B, Reifsnyder T. Venous duplex scanning for suspected deep vein thrombosis: results before and after elimination of after-hour studies. Vascular and Endovascular Surgery 2010; 44(5): 329-33.

  18. Huerta Vinalay A, Decuir-Díaz. Prevalencia de la trombosis venosa profunda. Rev Sanid Milit Mex 2006; 60(6): 383-9.

  19. Kearon C. Natural history of venous thomboembolism. Circulation 2003; 107: 22.

  20. Olarte-Casas MA, et al. Tromboembolismo pulmonar asintomático en pacientes con trombosis venosa profunda. Rev Mex Angiol 2011; 39(3): 101.

  21. PIOPED investigators. Value of ventilation/perfusion scan in acute pulmonary embolism. JAMA 1990; 263: 2753-9.

  22. Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000; 132(3): 227-32.

  23. Rocha A, Tapson V. Venous thromboembolism in intensive care patients. Clin Chest Med 2003; 24: 103-22.

  24. Guía de Práctica Clínica Diagnóstico y Tratamiento de la Enfermedad Tromboembólica Venosa. México: Secretaría de Salud; 2010.

  25. Majluf A, García J, Martínez C. Enfermedad tromboembólica venosa: diagnóstico, prevención y tratamiento. Garmarte Editorial; 2006.

  26. Cronenwett J, Gloviczki P, Johnston KW, Krupski W, Ouriel K, Sidawy A. Rutherford: Cirugía vascular. 6a Ed. Vol. 2: 2006; p. 2157-78.

  27. Kearon C, Akl E, Comerota A, Prandoni P, Bounameaux H, Goldhaber S, Nelson M, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based clinical practice guidelines. Chest 2012; 141; e419S-e494S.

  28. Van Dongen CJ, Van der Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews 2004; 4. Art. No.: CD001100. DOI: 10.1002/14651858.CD001100.pub2.

  29. Ageno W, Gallus A, Wittkowsky A, Pharm D, Crowther M, Hylek E, Palareti G. Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis 9th ed: American college of chest physicians Evidence-Based clinical practice guidelines. Chest 2012; 141(2) (Suppl.): e44S-e88S.

  30. Fuentes del Toro S, Enríquez E, Ayala E. Tratamiento quirúrgico de la enfermedad tromboembólica venosa. Gac Med Mex 2007; 143(Supl. 1): 45-6.

  31. Ríos-Reina J, Vargas C. Filtros en vena cava inferior. Acta Médica Grupo Ángeles 2006; 4(2).




2020     |     www.medigraphic.com